Skip to main content

The CTSI offers several funding opportunities that each releases its own FOA. Information about these opportunities can be found on this page.

The CTSI is funded by the National Center for Advancing Translational Sciences (NCATS), an NIH Center. Pilot and K12 projects funded through the CTSI must meet all NIH requirements.

Most CTSI proposals receive three formal reviews: two that are internal to the University and one external by NCATS. CTSI highest scoring proposals that include human or animal research receive a Just-in-Time (JIT) letter. The JIT letter explains the information and documents required for the NCATS review. This review by NCATS is called the Prior Approval (PA) process.

This page contains several frequently asked questions about the CTSI internal funding process. In addition, there are CTSI staff available to assist you through this process—their contact information is provided below.

  •  

  • *The NIH definition of a clinical trial can include minimal risk studies, therefore, even if your IRB determination letter states “minimal risk” it can meet the NIH definition of a clinical trial.

     

    If you answer ‘Yes’ to all of the following questions, your study meets the NIH definition of a clinical trial and, therefore, must meet NIH requirements for clinical trials.  See this NIH webpage for assistance

     

    1. Does the study involve human participants?

     

    1. Are the participants prospectively assigned to an intervention

     

    1. Is the study designed to evaluate the effect of the intervention on the participants?

     

    1. Is the effect being evaluated a health-related biomedical or behavioral outcome?
    • Even though the acronyms are similar, PMID and PMCID numbers are different and come from different systems. An article may be in PubMed and have a PubMed number; however it also needs to be submitted to PubMed Central to be compliant with the NIH Public Access policy.